Caixin
Oct 30, 2021 08:00 AM

Guangdong Biolight Meditech Co.,Ltd.’s Net Profit Dropped 78.4% in First Three Quarters of 2021

Guangdong Biolight Meditech Co.,Ltd. (广东宝莱特医用科技股份有限公司) (300246.SZ) reported a net profit of 69.7 million yuan in the first three quarters of 2021, down 78.4% year-on-year.

Meanwhile, the company posted 783.4 million yuan in revenue, down 28.9% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 680 million yuan in total liabilities, with a liability-to-asset ratio of 39.9%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST